A detailed history of Mission Wealth Management, LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mission Wealth Management, LP holds 57,256 shares of EW stock, worth $3.78 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
57,256
Previous 57,199 0.1%
Holding current value
$3.78 Million
Previous $5.47 Million 3.24%
% of portfolio
0.14%
Previous 0.14%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$84.3 - $94.31 $4,805 - $5,375
57 Added 0.1%
57,256 $5.29 Million
Q1 2024

Apr 30, 2024

SELL
$72.54 - $95.56 $3,409 - $4,491
-47 Reduced 0.08%
57,199 $5.47 Million
Q4 2023

Feb 05, 2024

SELL
$61.71 - $77.76 $59,920 - $75,504
-971 Reduced 1.67%
57,246 $4.37 Million
Q3 2023

Oct 23, 2023

BUY
$69.28 - $93.38 $1,524 - $2,054
22 Added 0.04%
58,217 $4.03 Million
Q2 2023

Aug 04, 2023

SELL
$81.41 - $94.33 $386,860 - $448,256
-4,752 Reduced 7.55%
58,195 $5.49 Million
Q1 2023

Apr 07, 2023

SELL
$74.26 - $84.51 $2,747 - $3,126
-37 Reduced 0.06%
62,947 $5.21 Million
Q4 2022

Feb 02, 2023

BUY
$68.3 - $87.44 $11,542 - $14,777
169 Added 0.27%
62,984 $4.7 Million
Q3 2022

Oct 12, 2022

SELL
$82.37 - $107.29 $19,439 - $25,320
-236 Reduced 0.37%
62,815 $5.19 Million
Q2 2022

Jul 27, 2022

BUY
$86.5 - $128.27 $13,494 - $20,010
156 Added 0.25%
63,051 $6 Million
Q1 2022

Apr 25, 2022

SELL
$101.96 - $128.34 $2.29 Million - $2.89 Million
-22,497 Reduced 26.35%
62,895 $7.4 Million
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $118,496 - $145,577
1,114 Added 1.32%
85,392 $11.1 Million
Q3 2021

Nov 05, 2021

SELL
$102.91 - $122.75 $407,111 - $485,599
-3,956 Reduced 4.48%
84,278 $9.54 Million
Q2 2021

Aug 10, 2021

SELL
$83.84 - $104.76 $534,647 - $668,054
-6,377 Reduced 6.74%
88,234 $9.14 Million
Q1 2021

May 10, 2021

SELL
$78.68 - $90.67 $353,823 - $407,742
-4,497 Reduced 4.54%
94,611 $7.91 Million
Q4 2020

Jan 19, 2021

SELL
$71.69 - $91.23 $859,204 - $1.09 Million
-11,985 Reduced 10.79%
99,108 $9.04 Million
Q3 2020

Oct 16, 2020

SELL
$67.19 - $87.44 $342,467 - $445,681
-5,097 Reduced 4.39%
111,093 $8.87 Million
Q2 2020

Aug 03, 2020

BUY
$57.54 - $76.95 $4.17 Million - $5.57 Million
72,448 Added 165.63%
116,190 $8.03 Million
Q1 2020

Apr 10, 2020

SELL
$52.41 - $81.0 $360,318 - $556,875
-6,875 Reduced 13.58%
43,742 $8.25 Million
Q4 2019

Jan 21, 2020

SELL
$71.7 - $82.09 $71,628 - $82,007
-999 Reduced 1.94%
50,617 $11.8 Million
Q3 2019

Oct 16, 2019

SELL
$61.55 - $75.43 $16,003 - $19,611
-260 Reduced 0.5%
51,616 $11.4 Million
Q2 2019

Aug 09, 2019

SELL
$55.74 - $64.41 $69,842 - $80,705
-1,253 Reduced 2.36%
51,876 $9.58 Million
Q4 2018

Feb 08, 2019

SELL
$46.41 - $56.94 $184,758 - $226,678
-3,981 Reduced 6.97%
53,129 $8.14 Million
Q3 2018

Nov 01, 2018

BUY
$45.7 - $58.03 $2.61 Million - $3.31 Million
57,110 New
57,110 $9.94 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Mission Wealth Management, LP Portfolio

Follow Mission Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.